PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTION
Main Author: | |
---|---|
Publication Date: | 2019 |
Other Authors: | , , |
Format: | Article |
Language: | eng |
Source: | ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) |
Download full: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-67202019000100502 |
Summary: | ABSTRACT Introduction: Pancreatic neuroendocrine tumors (pNET) correspond to about 3% of all tumors in pancreas and could be presented as a difficult diagnosis and management. Objective: To review the diagnosis and treatment of the pNET available in scientific literature. Method: A bibliographic survey was performed by means of an online survey of MeSH terms in the Pubmed database. A total of 104 articles were published in the last 15 years, of which 23 were selected as the basis for the writing of this article. Results: pNET is an infrequent neoplasia and their incidence, in USA, is about 1:100.000 inhabitants/year. Thereabout 30% of them produce hormones presenting as a symptomatic disease and others 70% of the cases could be silent disease. Magnetic Resonance Imaging (MRI) and/or Computed Tomography (CT) have similar sensitivy to detect pNET. They are very important when associated to nuclear medicine mainly Positron Emission Tomography (PET-CT) Gallium-68 to find primary tumor and its staging. The appropriate treatment should be chosen based on characteristics of the tumor, its staging and associated comorbidities. Conclusion: The surgical resection is still the best treatment for patients with ressectable pancreatic NETs. However, the size, grade, tumor functionality, stage and association with multiple endocrine neoplasia type 1 (MEN-1) are important to define who will be eligible for surgical treatment. In general, tumors bigger than 2 cm are eligible for surgical treatment, except insulinomas whose surgical resection is recommended no matter the size. |
id |
CBCD-1_5c89eec9bcc0e1e75ca34f2d3d240d76 |
---|---|
oai_identifier_str |
oai:scielo:S0102-67202019000100502 |
network_acronym_str |
CBCD-1 |
network_name_str |
ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) |
repository_id_str |
|
spelling |
PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTIONNeuroendocrine tumorPancreatic neoplasmPancreasABSTRACT Introduction: Pancreatic neuroendocrine tumors (pNET) correspond to about 3% of all tumors in pancreas and could be presented as a difficult diagnosis and management. Objective: To review the diagnosis and treatment of the pNET available in scientific literature. Method: A bibliographic survey was performed by means of an online survey of MeSH terms in the Pubmed database. A total of 104 articles were published in the last 15 years, of which 23 were selected as the basis for the writing of this article. Results: pNET is an infrequent neoplasia and their incidence, in USA, is about 1:100.000 inhabitants/year. Thereabout 30% of them produce hormones presenting as a symptomatic disease and others 70% of the cases could be silent disease. Magnetic Resonance Imaging (MRI) and/or Computed Tomography (CT) have similar sensitivy to detect pNET. They are very important when associated to nuclear medicine mainly Positron Emission Tomography (PET-CT) Gallium-68 to find primary tumor and its staging. The appropriate treatment should be chosen based on characteristics of the tumor, its staging and associated comorbidities. Conclusion: The surgical resection is still the best treatment for patients with ressectable pancreatic NETs. However, the size, grade, tumor functionality, stage and association with multiple endocrine neoplasia type 1 (MEN-1) are important to define who will be eligible for surgical treatment. In general, tumors bigger than 2 cm are eligible for surgical treatment, except insulinomas whose surgical resection is recommended no matter the size.Colégio Brasileiro de Cirurgia Digestiva2019-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-67202019000100502ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) v.32 n.1 2019reponame:ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)instname:Colégio Brasileiro de Cirurgia Digestiva (CBCD)instacron:CBCD10.1590/0102-672020180001e1428info:eu-repo/semantics/openAccessBELOTTO,MarcosCROUZILLARD,Bruna do Nascimento SantosARAUJO,Karla de OliveiraPEIXOTO,Renata D’Alpinoeng2019-02-05T00:00:00Zoai:scielo:S0102-67202019000100502Revistahttp://abarriguda.org.br/revista/index.php/revistaabarrigudaarepb/indexONGhttps://old.scielo.br/oai/scielo-oai.php||revistaabcd@gmail.com2317-63262317-6326opendoar:2019-02-05T00:00ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) - Colégio Brasileiro de Cirurgia Digestiva (CBCD)false |
dc.title.none.fl_str_mv |
PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTION |
title |
PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTION |
spellingShingle |
PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTION BELOTTO,Marcos Neuroendocrine tumor Pancreatic neoplasm Pancreas |
title_short |
PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTION |
title_full |
PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTION |
title_fullStr |
PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTION |
title_full_unstemmed |
PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTION |
title_sort |
PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTION |
author |
BELOTTO,Marcos |
author_facet |
BELOTTO,Marcos CROUZILLARD,Bruna do Nascimento Santos ARAUJO,Karla de Oliveira PEIXOTO,Renata D’Alpino |
author_role |
author |
author2 |
CROUZILLARD,Bruna do Nascimento Santos ARAUJO,Karla de Oliveira PEIXOTO,Renata D’Alpino |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
BELOTTO,Marcos CROUZILLARD,Bruna do Nascimento Santos ARAUJO,Karla de Oliveira PEIXOTO,Renata D’Alpino |
dc.subject.por.fl_str_mv |
Neuroendocrine tumor Pancreatic neoplasm Pancreas |
topic |
Neuroendocrine tumor Pancreatic neoplasm Pancreas |
description |
ABSTRACT Introduction: Pancreatic neuroendocrine tumors (pNET) correspond to about 3% of all tumors in pancreas and could be presented as a difficult diagnosis and management. Objective: To review the diagnosis and treatment of the pNET available in scientific literature. Method: A bibliographic survey was performed by means of an online survey of MeSH terms in the Pubmed database. A total of 104 articles were published in the last 15 years, of which 23 were selected as the basis for the writing of this article. Results: pNET is an infrequent neoplasia and their incidence, in USA, is about 1:100.000 inhabitants/year. Thereabout 30% of them produce hormones presenting as a symptomatic disease and others 70% of the cases could be silent disease. Magnetic Resonance Imaging (MRI) and/or Computed Tomography (CT) have similar sensitivy to detect pNET. They are very important when associated to nuclear medicine mainly Positron Emission Tomography (PET-CT) Gallium-68 to find primary tumor and its staging. The appropriate treatment should be chosen based on characteristics of the tumor, its staging and associated comorbidities. Conclusion: The surgical resection is still the best treatment for patients with ressectable pancreatic NETs. However, the size, grade, tumor functionality, stage and association with multiple endocrine neoplasia type 1 (MEN-1) are important to define who will be eligible for surgical treatment. In general, tumors bigger than 2 cm are eligible for surgical treatment, except insulinomas whose surgical resection is recommended no matter the size. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-67202019000100502 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-67202019000100502 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/0102-672020180001e1428 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Colégio Brasileiro de Cirurgia Digestiva |
publisher.none.fl_str_mv |
Colégio Brasileiro de Cirurgia Digestiva |
dc.source.none.fl_str_mv |
ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) v.32 n.1 2019 reponame:ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) instname:Colégio Brasileiro de Cirurgia Digestiva (CBCD) instacron:CBCD |
instname_str |
Colégio Brasileiro de Cirurgia Digestiva (CBCD) |
instacron_str |
CBCD |
institution |
CBCD |
reponame_str |
ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) |
collection |
ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) |
repository.name.fl_str_mv |
ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) - Colégio Brasileiro de Cirurgia Digestiva (CBCD) |
repository.mail.fl_str_mv |
||revistaabcd@gmail.com |
_version_ |
1754208958658117632 |